Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.83
+0.06 (1.04%)
Sep 18, 2025, 10:13 AM EDT - Market open
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $39.27 million as of September 18, 2025. Its market cap has decreased by -77.71% in one year.
Market Cap
39.27M
Enterprise Value
-17.17M
1-Year Change
-77.71%
Ranking
Category
Stock Price
$5.83
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $39.27M, a decrease of -96.34%. That is a compound annual growth rate of -46.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 38.86M | -45.11% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.83B |
| Johnson & Johnson | 426.61B |
| AbbVie | 388.11B |
| UnitedHealth Group | 307.95B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.60B |